Multiple sclerosis patients in California and across the country have watched an intellectual property dispute play out in the pharmaceutical arena that could have a major influence on the price of a key drug in MS treatment. Copaxone, patented by Teva Pharmaceuticals, is one of the most widely prescribed treatments for relapsing multiple sclerosis. From August 2017 to 2018, $2.86 billion in 40 mg/mL doses were sold as well as $527 million in 20 mg/mL doses.
Even small, independent businesses in California could face trademark infringement lawsuits from major corporations. In one such case, Vogue, the famous fashion magazine owned by Advance Publications, has filed a lawsuit for trademark infringement against a 26-year-old designer and activist who created a line of shirts and other items bearing the words "Black Vogue" in a similar font to the magazine's famous header.